This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novaonco Js Therapeutics Co., Ltd.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Jian Zuo in Immunomodulation
Introduction: Jian Zuo, an accomplished inventor based in Shanghai, China, has made significant strides in the field of immunology. With a focus on developing novel compounds, his research primarily revolves around enhancing the body's immune response to target specific diseases.
Latest Patents: Jian Zuo holds a patent for a groundbreaking invention titled "Vinylpyridine Carboxamide Compound as PD-L1 Immunomodulator." This patent discloses a PD-L1 inhibitor, specifically featuring a compound of formula (I), which serves as a PD-L1 immunomodulator. It includes a pharmaceutically acceptable salt or an isomer thereof, indicating its potential therapeutic applications.
Career Highlights: Jian Zuo is currently associated with Novaonco Js Therapeutics Co., Ltd., where he leverages his expertise in immunology to contribute to innovative therapeutic solutions. His work not only advances scientific understanding but also addresses critical healthcare challenges.
Collaborations: Throughout his career, Jian has collaborated with notable colleagues such as Shuhui Chen and Yuanfeng Xia. These partnerships exemplify the importance of teamwork in pioneering research and development within the biotech sector.
Conclusion: Jian Zuo's contributions to the field of immunomodulation through his innovative patent highlight his role as a key inventor in the industry. With ongoing collaborations and research, he continues to push the boundaries of scientific knowledge and therapeutic advancements, positioning himself as a leader in his domain.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile